- Home
- UNH vs LLY Comparison
UNH vs LLY Comparison
Compare UNH & LLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UNH | LLY |
|---|---|---|
| Founded | 1977 | 1876 |
| Country | United States | United States |
| Employees | 390000 | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 338.3B | 994.5B |
| IPO Year | 2010 | 2007 |
Fundamental Metrics
Financial Performance| Metric | UNH | LLY |
|---|---|---|
| Price | $374.04 | $1,168.48 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 26 | 19 |
| Target Price | $384.50 | ★ $1,218.84 |
| AVG Volume (30 Days) | ★ 4.0M | 1.5M |
| Earning Date | 04-21-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.38% | 0.81% |
| EPS Growth | N/A | ★ 95.99 |
| EPS | 12.94 | ★ 16.19 |
| Revenue | ★ $447,567,000,000.00 | $65,179,000,000.00 |
| Revenue This Year | N/A | $27.15 |
| Revenue Next Year | $3.64 | $16.04 |
| P/E Ratio | ★ $29.18 | $71.92 |
| Revenue Growth | 11.81 | ★ 44.70 |
| 52 Week Low | $255.97 | $712.05 |
| 52 Week High | $461.62 | $1,292.65 |
Technical Indicators
Market Signals| Indicator | UNH | LLY |
|---|---|---|
| Relative Strength Index (RSI) | 40.87 | 45.09 |
| Support Level | $358.25 | $1,118.95 |
| Resistance Level | $405.64 | $1,182.73 |
| Average True Range (ATR) | 9.45 | 22.01 |
| MACD | -0.61 | 1.59 |
| Stochastic Oscillator | 23.20 | 41.49 |
Price Performance
Historical ComparisonAbout UNH UnitedHealth Group
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2025. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to affiliates and third parties.
About LLY Eli Lilly and Company
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.